| Dr William Enoch Sterling Jr, OD | |
|
407 Avenue K Se, Winter Haven, FL 33880-4126 | |
| (863) 294-3504 | |
| Not Available |
| Full Name | Dr William Enoch Sterling Jr |
|---|---|
| Gender | Male |
| Speciality | Optometrist |
| Location | 407 Avenue K Se, Winter Haven, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255447389 | NPI | - | NPPES |
| 078081200 | Medicaid | FL | |
| 0PC001313 | Other | FL | OPTOMETRY LICENSE NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 0PC001313 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr William Enoch Sterling Jr, OD 407 Avenue K Se, Winter Haven, FL 33880-4126 Ph: (863) 294-3504 | Dr William Enoch Sterling Jr, OD 407 Avenue K Se, Winter Haven, FL 33880-4126 Ph: (863) 294-3504 |
News Archive
Georgia Tech and Emory University have received a five-year $14.6 million contract from the National Institutes of Health (NIH) to continue the development of nanotechnology and biomolecular engineering tools and methodologies for detecting and treating atherosclerosis.
Sen. Chuck Grassley (R-Iowa) has sent a letter to Merck Chief Operating Officer Richard Clark requesting the company explain a recent report that found the company used employees or paid consultants rather than the physicians listed as lead authors to write several published studies of the COX-2 inhibitor Vioxx, CQ HealthBeat reports.
In this brief, researchers analyze the cost burden associated with excess rates of diseases such as diabetes, hypertension, stroke and renal disease among Hispanics and African Americans relative to non-Hispanic whites. The study predicts that in 2009, "Medicare alone will spend an extra $15.6 billion while private insurers will incur $5.1 billion in additional costs due to elevated rates of chronic illness among African Americans and Hispanics."
Watson Pharmaceuticals, Inc. has announced today that it has received final approval from the U.S. Food and Drug Administration ("FDA") of its Abbreviated New Drug Application (ANDA) for Omeprazole Delayed-Release Capsules USP in the 10mg, 20mg and 40mg strengths.
› Verified 6 days ago
Edward Attaway, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 407 Avenue K Se, Winter Haven, FL 33880 Phone: 863-294-3504 Fax: 863-294-8305 | |
Dr. John Tivnan, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 407 Avenue K Se, Winter Haven, FL 33880 Phone: 863-294-3504 Fax: 863-299-0096 | |
Sonya Braudway, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 250 Avenue K Sw, Suite 200, Winter Haven, FL 33880 Phone: 863-297-5400 Fax: 863-293-8230 | |
Thomas W Hegland, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 407 Avenue K Se, Winter Haven, FL 33880 Phone: 863-294-3504 Fax: 866-522-3607 | |
Dr. Thomas Brinton, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 407 Avenue K Se, Winter Haven, FL 33880 Phone: 863-294-3504 Fax: 863-294-8305 | |
Katie M Salomon, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 570 Avenue K Se, Winter Haven, FL 33880 Phone: 863-401-4200 Fax: 863-220-9912 | |
Dr. John Linden Davidson, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 407 Avenue K Se, Winter Haven, FL 33880 Phone: 863-294-3504 Fax: 863-294-8305 |